< Back to all Breaking News
OCGN
10/9/2019 07:10am
Ocugen expects topline results for Phase 3 study of OCU300 in 2H20 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
